Michael J Roe, is Senior Director of Development & Industrialisation at Kaléo. He leads a team that develops autoinjectors and on-body delivery systems, as well as connected health and digital solutions. Mr Roe has published articles and presented in the areas of innovation, device development and drug delivery, and holds several patents. Prior to joining Kaléo he spent over 20 years at Eli Lilly and Company in device development.
Mr Roe has degrees in Engineering and Business from Duke University (Durham, NC, US) and is a registered Professional Engineer. He serves as convener of the ISO Technical Committee 84, which is responsible for injection device standards.